Skytrofa TM
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional.
Active ingredients: inert substance, lonapegsomatropin, somatropin
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 7.6 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 13.3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 4.3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 4.3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 6.3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 6.3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 9.1 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 3.6 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 3.6 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 9.1 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 13.3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 5.2 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 7.6 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 11 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
Brand name
(ARTG)
: SKYTROFA lonapegsomatropin 3 mg powder and solvent for solution for injection dual chamber glass cartridgeConsumer Medicine Information (CMI)
Read the CMI leaflet for facts you need to know before, during and after taking your medicine.
For more information about CMIs and how to read them, please visit How to read Consumer Medicine Information (CMI).
What this medicine is used for
(ARTG)
Growth failure in children and adolescents aged from 3 years up to 18 years due to insufficient endogenous growth hormone secretion.
How to use this medicine
(ARTG)
This medicine contains one component only.
Component :
- Injection, powder for
- Subcutaneous
- White to off white powder
Storage conditions
(ARTG)
- Store at 2 to 8 degrees Celsius
- Protect from Light
- Do not Freeze
- Store in Original Container
- Reconstituted Solution see label for shelf life
- Shelf lifetime is 60 Months.
Do I need a prescription ?
(ARTG)
These medicine packs are available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.
- A dual chamber glass cartridge and needle pack
Pregnant or planning a pregnancy ?
(AHT)
For the active ingredient lonapegsomatropin
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.
- You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
- For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme
